FindTrial
Sign In

Wide-field swept source optical coherence tomography angiography for objective evaluation of proliferative diabetic retinopathy

Wide-field swept source optical coherence tomography angiography for objective evaluation of proliferative diabetic retinopathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060385
Enrollment
Unknown
Registered
2022-05-30
Start date
2022-05-30
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic retinopathy

Interventions

Gold Standard:Fundus fluorescein angiography
Index test:Wide-field swept source optical coherence tomography angiography

Sponsors

Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with diabetic retinopathy; 2. Patients who have undergone fundus fluorescein angiography clinically; 3. Patients or their family members sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Cataracts obviously obscure the fundus; 2. Obvious eye movement, unable to cooperate; 3. Suffering from other serious systemic diseases except diabetes, hypertension and diabetic nephropathy; 4. Other inner eye surgeries except cataract surgeries have been performed in the past.

Design outcomes

Primary

MeasureTime frame
Microhemangioma;Microvascular abnormalities;Neovascularization;Sensitivity;Specificity;Positive predictive value;Negative predictive value;—

Countries

China

Contacts

Public ContactLi Jie

Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital

3442252696@qq.com+86 13281080298

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026